EUVIMEDEUVIMED entdecken
Crossref

Disproportionality analysis of adverse events associated with bimekizumab: a real-world study based on FDA Adverse Event Reporting System (FAERS) Database

Xiaojuan Lin, Liwei Guo, Tian Lin, Chen Yan, Xiaohong Huang, Yu Cheng, Maohua Chen

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04894-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Xiaojuan Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, China. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Joint Funds for the innovation of science and Technology,Fujian province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsAntibodies, Monoclonal, HumanizedHumansUnited StatesPharmacovigilanceUnited States Food and Drug AdministrationMaleDatabases, FactualRetrospective StudiesFemaleMiddle AgedAdultAgedYoung AdultAdolescent

Stichwörter der Autor:innen

Adverse eventsBimekizumabFAERSInterleukin-17A and F antagonistPharmacovigilance study

Substanzen

Antibodies, Monoclonal, Humanizedbimekizumab

Autor:innen und Institutionen

  • Department of Pharmacy, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, China.
  • Department of Medical Administration, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, 363000, China.
  • Department of Pharmacy, Fujian Medical University Union Hospital, 29 Xin Quan Rd., Gulou, Fuzhou, Fujian, 350001, China.
  • School of Pharmacy, Fujian Medical University, Fuzhou, 350001, China.
  • Department of Pharmacy, Pingtan Comprehensive Experimental Area Hospital, No. 2, Linhu 7th Road, Pingtan Comprehensive Experimental Area, Fuzhou, Fujian, 350400, China.
  • Department of Pharmacy, Fujian Medical University Union Hospital, 29 Xin Quan Rd., Gulou, Fuzhou, Fujian, 350001, China. chengyu@fjmu.edu.cn.

Förderung

  • Joint Funds for the innovation of science and Technology,Fujian province

Zitieren

APA

Lin, X., Guo, L., Lin, T., Yan, C., Huang, X., Cheng, Y., & Chen, M. (2026). Disproportionality analysis of adverse events associated with bimekizumab: a real-world study based on FDA Adverse Event Reporting System (FAERS) Database. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04894-2

Vancouver

Lin X, Guo L, Lin T, Yan C, Huang X, Cheng Y, et al. Disproportionality analysis of adverse events associated with bimekizumab: a real-world study based on FDA Adverse Event Reporting System (FAERS) Database. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04894-2

BibTeX
@article{Lin2026,
  author = {Lin, Xiaojuan and Guo, Liwei and Lin, Tian and Yan, Chen and Huang, Xiaohong and Cheng, Yu and Chen, Maohua},
  title = {Disproportionality analysis of adverse events associated with bimekizumab: a real-world study based on FDA Adverse Event Reporting System (FAERS) Database},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04894-2}
}
Kostenlos starten →